Home / Inspections / 1175277

FDA Inspection 1175277 — Reproductive Institute of South Texas

Reproductive Institute of South Texas — FEI 3004611200

The FDA completed an inspection of Reproductive Institute of South Texas on July 11, 2022 in Mcallen, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 11, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Mcallen, TX (United States)

Facility

Other inspections at this facility

  • 1048356 (VAI Mon Apr 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 960804 (VAI Thu Jan 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 844699 (VAI Fri Aug 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 794470 (OAI Fri Aug 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources